<DOC>
	<DOCNO>NCT02330718</DOCNO>
	<brief_summary>The purpose study elucidate factor associate diagnosis predict prognosis therapeutic target collect specimen tissue sample , peripheral blood , bone marrow aspirate time diagnosis relapse/refractory patient malignant hematologic disorder except acute leukemia . This study eligible patient diagnose malignant hematologic disorder except acute leukemia diagnostic procedure suspicion hematologic malignancy . Prospective cohort patient treatment hematologic malignancy . Retrospective cohort patient diagnose treatment .</brief_summary>
	<brief_title>Prospective Retrospective Cohort Study Find New Prognostic Factors Therapeutic Targets Patients With Newly Diagnosed Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>The patient malignant hematologic disorder except acute leukemia diagnose pathologically accord revise 2008 WHO classification tumour haematopoietic lymphoid tissue diagnostic procedure suspicion hematologic malignancy . Any gender age â‰¥ 19 year Written inform consent Diagnosed 20050101 retrospective cohort group . Patients understand disagree informed consent Patients diagnose acute leukemia</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>